MOHAMMAD SAAD SALIM NAVIWALA

As a detail-oriented medical professional specializing in oncology, I am committed to advancing my expertise in gastrointestinal, thoracic, and male genitourinary cancers. I am passionate about patient care, early detection, clinical research, and academic teaching, with a dedication to lifelong learning and contribution to multidisciplinary oncology practice.

· Naviwala MSS , Tariq M, Ahmed F, et al. Overall Survival and the Impact of Albumin-Bilirubin Grade in Patients with Advanced Hepatocellular Carcinoma: Data from a Tertiary Care Hospital in a Lower-Middle-Income Country. Euroasian Journal of Hepato-Gastroenterology. 2024;14(2):251-257.

· Naviwala MSS , Shoaib D, Khan WA, et al. Complete Response with Immunotherapy Alone after Discontinuing VEGF Inhibitor in Advanced Hepatocellular Carcinoma: A Case Report. Euroasian Journal of Hepato-Gastroenterology. 2024;14(2):246–250.

· Nasir S, Ali I, Naviwala MSS , Alidina Z, Idrees H, Moosajee M, et al. Comparative Efficacy and Safety Profiles Between Conventional Peg filgrastim and Its Biosimilar Agents in Patients Receiving Cytotoxic Chemotherapy: A Systemic Review and Meta-Analysis. ASCO Annual Meeting Abstracts. 2024. Abstract 12115.

· Zehra SRE, Abidi SMA, Nazir L, Perveen T, Hussain SNF, Jaffri SA, Jawed M, Naviwala MSS , Khan HA, Ghouri KMU. Juvenile Idiopathic Arthritis in Focus: A Holistic Examination of Clinical Profiles, Diagnostics, and Individualized Treatment Approaches in Southern Pakistan. The Research of Medical Science Review. 2024;14(3):374–382.

· Khan WA, Naviwala MSS . The Power of Patient-Reported Outcomes in Oncology Practice. Journal of the College of Physicians and Surgeons Pakistan (JCPSP). 2024;34(9):1007–1008.

· Hina M, Naviwala MSS , Moosajee M, Ali N. Recurrent Cutaneous Manifestation in Multiple Myeloma: A Case Report. BMJ Case Reports. 2024;17(8):e260485.

· Naviwala MSS , Samar MR, Shoaib D, Akbar F, Idrees R, Rashid YA. Esophageal Squamous Cell Carcinoma in a Patient with BRCA1 Mutation: A Rare Association. eCancer Medical Science. 2024; 18:1730.

· Naviwala MSS , Dawood T, Uddin Z, Chundriger Q, Jalbani IK. The Transition from Localized to Metastatic: A Case Report of Adult TFE3-Positive Xp11.2 Translocation Renal Cell Carcinoma. Cureus. 2023;15(8): e43378.

· Naviwala MSS . BRCA2 Mutation in Lung Adenocarcinoma: A Case Report. Oxford Medical Case Reports. 2024;2024(3): omad009.

· Naviwala MSS , Tariq M, Ahmed F, et al. Assessing the Predictive Value of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Advanced Hepatocellular Carcinoma. Euroasian Journal of Hepato-Gastroenterology. 2024;14(2):258–264.

· Naviwala MSS , Tariq M, Ahmed F, et al. Impact of Clinical Outcomes and Prognostic Nutritional Index in Patients with Advanced Pancreatic Cancer. Euroasian Journal of Hepato-Gastroenterology. 2024;14(2):265–270.

- CDK4/6 Inhibitors in Metastatic HR+ Breast Cancer. (Submitted to Asian Pacific Journal of Clinical Oncology)

- Clinical Outcomes of EGFR-Mutated NSCLC. (Submitted to e-Cancer Medical Science)

- Atezolizumab-Induced Myasthenia Gravis in HCC. (Submitted to Frontiers Journal)

- Clinical Outcomes in Nasopharyngeal Carcinoma. (In Progress)

- Hidden in the Adrenals: De Novo CD20-Negative DLBCL. (Submitted)

· Early Non-Small Cell Lung Cancer: Case Presentation. Best of ASCO, Lahore, 2023.

· Selected Presenter. ESMO Preceptorship on Gastric Cancer, Singapore, November 2023.

· Presented abstracts on ovarian cancer at Best of ASCO, Karachi, 2024.

· Presented an oral presentation on "Outcomes with First-Line Therapy and Impact of ALBI Grade in Advanced HCC" at the Asian Oncology Society (AOS) 2024 in Xi'an, China; awarded a travel grant for this presentation.

· Presented poster on Overall Survival and the Impact of ALBI Grade in Advanced HCC. ESMO Asia 2024, Singapore.

· Hidden in the Adrenals: De Novo CD20-Negative DLBCL - Diagnostic Challenges. IACH 2024, Paris (virtual).

· TFE3 Positive Xp11.2 Translocation Renal Cell Carcinoma: A Case Report. Shaukat Khanum Cancer Symposium, Peshawar, 2023.

• SCE in Medical Oncology, 2024
• ASH International Outreach Initiative Awardee, 2024
• Third Place, Jeopardy Competition, Best of ASCO Lahore, 2023

• Society of Medical Oncology Pakistan (SMOP)
• European Society of Medical Oncology (ESMO)
• American Society of Clinical Oncology (ASCO)
• Asian Oncology Society (AOS)

· Executive Committee Member of RECON, an officially ASCO-recognized educational network under SMOP, dedicated to enhancing oncology education and mentorship.
RECON is registered under ASCO’s official educational resources platform.

· Conducted an internal official audit during medical oncology residency at Aga Khan University Hospital (AKU).

· Organized Cancer Awareness Walk (February 2022)

· Organized Breast Cancer Awareness 'Pink Party' (October 2022)

· Conducted Breast Cancer Awareness Sessions at AKU.